Leaflet FOSRENOL 500mg chewable tablets

Product code:
W66746001
Quantity:
20
Indicated for:
hyperphosphatemia
Route of administration:
oral
Substance:
lanthanum (phosphate binder)
ATC
V03AE03 — Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia
Lanthanum is a chemical element used in medicine in the form of lanthanum carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease. It works by binding phosphates from food in the digestive tract, thereby reducing blood phosphorus levels.

The medication is taken orally, usually during meals, to maximize effectiveness. It is important for patients to follow a low-phosphorus diet during treatment.

Side effects may include nausea, diarrhea, constipation, or abdominal discomfort. In rare cases, allergic reactions or other complications may occur.

Patients should inform their doctor about any other medications they are taking, as drug interactions may occur. Pregnant or breastfeeding women should consult a specialist before use.

General data about FOSRENOL 500mg

Substance:
lanthanum
Date of latest medicines list:
01-10-2020
Product code:
W66746001
Concentration:
500mg
Pharmaceutical form:
chewable tablets
Quantity:
20
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SHIRE PHARMACEUTICAL CONTRACTS LIMITED - MAREA BRITANIE
Holder:
SHIRE PHARMACEUTICALS IRELAND LIMITED - IRLANDA
Number:
7353/2015/01
Shelf life:
3 years

Pharmaceutical forms available for lanthanum

Concentrations available for lanthanum

  • 1000mg
  • 250mg
  • 500mg
  • 750mg